MORGAN STAGGS: Open Payments
NPI 1598202228 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 51 payments from 26 companies in 2025. Trend: 2023 $1,400 · 2024 $1,502 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $179 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| Daiichi Sankyo Inc. | 3 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| BeOne Medicines USA, Inc. | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| SOBI, INC | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Blueprint Medicines Corporation | 1 | $24 |
Products named: KEYTRUDA, Enhertu, OPDIVO, CALQUENCE, BRUKINSA, PLUVICTO, IMFINZI, KISQALI.
Industry payments across AL — which companies pay providers there.
